{"count": 15, "results": [{"_id": "35935880", "pmid": 35935880, "pmcid": "PMC9355151", "title": "Metformin's effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study", "journal": "Front Pharmacol", "authors": ["Tseng CH"], "date": "2022-07-22T00:00:00Z", "doi": "10.3389/fphar.2022.799290", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "799290", "score": 50270.902, "text_hl": "., @DISEASE_Varicocele @DISEASE_MESH:D014646 @@@varicocele@@@, @DISEASE_Erectile_Dysfunction @DISEASE_MESH:D007172 @@@ED@@@, @DISEASE_Infertility @DISEASE_MESH:D007246 @@@infertility@@@, @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostatitis@@@, @DISEASE_Prostatic_Hyperplasia @DISEASE_MESH:D011470 @@@BPH@@@ and @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@, respectively) was compared between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ initiators [denoted by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (+)] and non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ initiators [denoted by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (-)]. ", "citations": {"NLM": "Tseng CH. Metformin's effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study Front Pharmacol. 2022;13():799290. PMID: 35935880", "BibTeX": "@article{35935880, title={Metformin's effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study}, author={Tseng CH}, journal={Front Pharmacol}, volume={13}, pages={799290}}"}}, {"_id": "40028423", "pmid": 40028423, "title": "Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review.", "journal": "Clin Transl Radiat Oncol", "authors": ["Portillo EGD", "Olivares-Hernández A", "Gudino LC", "Félix LC", "Hernández LB", "Domínguez LP", "Jiménez DL", "Sarmiento RG", "Morillo EDB", "Sánchez EF", "Miramontes-Gonzáleze JP"], "date": "2025-02-10T00:00:00Z", "doi": "10.1016/j.ctro.2025.100930", "meta_date_publication": "2025 May", "meta_volume": "52", "meta_issue": "", "meta_pages": "100930", "score": 50250.793, "text_hl": "Evaluation of the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a radiosensitiser in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@solid tumours@@@: A systematic review.", "citations": {"NLM": "Portillo EGD, Olivares-Hernández A, Gudino LC, Félix LC, Hernández LB, Domínguez LP, Jiménez DL, Sarmiento RG, Morillo EDB, Sánchez EF, Miramontes-Gonzáleze JP. Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review. Clin Transl Radiat Oncol. 2025 May;52():100930. PMID: 40028423", "BibTeX": "@article{40028423, title={Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review.}, author={Portillo EGD and Olivares-Hernández A and Gudino LC and Félix LC and Hernández LB and Domínguez LP and Jiménez DL and Sarmiento RG and Morillo EDB and Sánchez EF and Miramontes-Gonzáleze JP}, journal={Clin Transl Radiat Oncol}, volume={52}, pages={100930}}"}}, {"_id": "35267516", "pmid": 35267516, "pmcid": "PMC8909564", "title": "Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals", "journal": "Cancers (Basel)", "authors": ["Wang CH", "Huang CW", "Nguyen PA", "Lin MC", "Yeh CY", "Islam MM", "Rahmanti AR", "Yang HC"], "date": "2022-02-25T00:00:00Z", "doi": "10.3390/cancers14051211", "meta_date_publication": "2022 Feb 25", "meta_volume": "14", "meta_issue": "5", "meta_pages": "", "score": 50248.062, "text_hl": "Aspirin 21,691 (3.60) 92,676 (3.85)     3. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ 16,380 (2.72) 58,131 (2.42)     4. ", "citations": {"NLM": "Wang CH, Huang CW, Nguyen PA, Lin MC, Yeh CY, Islam MM, Rahmanti AR, Yang HC. Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals Cancers (Basel). 2022 Feb 25;14(5):. PMID: 35267516", "BibTeX": "@article{35267516, title={Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals}, author={Wang CH and Huang CW and Nguyen PA and Lin MC and Yeh CY and Islam MM and Rahmanti AR and Yang HC}, journal={Cancers (Basel)}, volume={14}, number={5}}"}}, {"_id": "35902376", "pmid": 35902376, "title": "Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.", "journal": "Clin Endocrinol (Oxf)", "authors": ["Lopez DS", "Malagaris I", "Polychronopoulou E", "Tsilidis KK", "Milani SA", "Kristen Peek M", "Villasante-Tezanos A", "Alzweri L", "Baillargeon J", "Kuo YF", "Canfield S"], "date": "2022-12-01T00:00:00Z", "doi": "10.1111/cen.14803", "meta_date_publication": "2022 Dec", "meta_volume": "97", "meta_issue": "6", "meta_pages": "792-803", "score": 50242.81, "text_hl": "RESULTS: We found independent and joint associations of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and TTh with incident @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate@@@ (odds ratio [OR]joint  = 0.44, 95% confidence interval [CI]: 0.36-0.54) and @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal cancers@@@ (ORjoint  = 0.47, 95% CI: 0.34-0.64), but not with @DISEASE_Breast_Neoplasms_Male @DISEASE_MESH:D018567 @@@male breast cancer@@@. ", "citations": {"NLM": "Lopez DS, Malagaris I, Polychronopoulou E, Tsilidis KK, Milani SA, Kristen Peek M, Villasante-Tezanos A, Alzweri L, Baillargeon J, Kuo YF, Canfield S. Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men. Clin Endocrinol (Oxf). 2022 Dec;97(6):792-803. PMID: 35902376", "BibTeX": "@article{35902376, title={Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.}, author={Lopez DS and Malagaris I and Polychronopoulou E and Tsilidis KK and Milani SA and Kristen Peek M and Villasante-Tezanos A and Alzweri L and Baillargeon J and Kuo YF and Canfield S}, journal={Clin Endocrinol (Oxf)}, volume={97}, number={6}, pages={792-803}}"}}, {"_id": "28253329", "pmid": 28253329, "pmcid": "PMC5333882", "title": "Metformin inhibits the proliferation of benign prostatic epithelial cells", "journal": "PLoS One", "authors": ["Wang Z", "Xiao X", "Ge R", "Li J", "Johnson CW", "Rassoulian C", "Olumi AF"], "date": "2017-03-02T00:00:00Z", "doi": "10.1371/journal.pone.0173335", "meta_date_publication": "2017", "meta_volume": "12", "meta_issue": "3", "meta_pages": "e0173335", "score": 50062.51, "text_hl": "However, the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on benign @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostatic@@@ cells still remains unclear. ", "citations": {"NLM": "Wang Z, Xiao X, Ge R, Li J, Johnson CW, Rassoulian C, Olumi AF. Metformin inhibits the proliferation of benign prostatic epithelial cells PLoS One. 2017;12(3):e0173335. PMID: 28253329", "BibTeX": "@article{28253329, title={Metformin inhibits the proliferation of benign prostatic epithelial cells}, author={Wang Z and Xiao X and Ge R and Li J and Johnson CW and Rassoulian C and Olumi AF}, journal={PLoS One}, volume={12}, number={3}, pages={e0173335}}"}}, {"_id": "28385910", "pmid": 28385910, "title": "Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways.", "journal": "Mol Cancer Res", "authors": ["Sarmento-Cabral A", "L-López F", "Gahete MD", "Castaño JP", "Luque RM"], "date": "2017-07-01T00:00:00Z", "doi": "10.1158/1541-7786.MCR-16-0493", "meta_date_publication": "2017 Jul", "meta_volume": "15", "meta_issue": "7", "meta_pages": "862-874", "score": 50061.7, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Reduces @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@Prostate Tumor@@@ Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways.", "citations": {"NLM": "Sarmento-Cabral A, L-López F, Gahete MD, Castaño JP, Luque RM. Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways. Mol Cancer Res. 2017 Jul;15(7):862-874. PMID: 28385910", "BibTeX": "@article{28385910, title={Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways.}, author={Sarmento-Cabral A and L-López F and Gahete MD and Castaño JP and Luque RM}, journal={Mol Cancer Res}, volume={15}, number={7}, pages={862-874}}"}}, {"_id": "25908508", "pmid": 25908508, "title": "Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice.", "journal": "Cancer Prev Res (Phila)", "authors": ["Saha A", "Blando J", "Tremmel L", "DiGiovanni J"], "date": "2015-07-01T00:00:00Z", "doi": "10.1158/1940-6207.CAPR-15-0014", "meta_date_publication": "2015 Jul", "meta_volume": "8", "meta_issue": "7", "meta_pages": "597-606", "score": 50060.094, "text_hl": "Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@Rapamycin@@@, and Their Combination on Growth and Progression of @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@Prostate Tumors@@@ in HiMyc @SPECIES_10090 @@@Mice@@@.", "citations": {"NLM": "Saha A, Blando J, Tremmel L, DiGiovanni J. Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice. Cancer Prev Res (Phila). 2015 Jul;8(7):597-606. PMID: 25908508", "BibTeX": "@article{25908508, title={Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice.}, author={Saha A and Blando J and Tremmel L and DiGiovanni J}, journal={Cancer Prev Res (Phila)}, volume={8}, number={7}, pages={597-606}}"}}, {"_id": "25053577", "pmid": 25053577, "pmcid": "PMC4433365", "title": "Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality", "journal": "J Am Med Inform Assoc", "authors": ["Xu H", "Aldrich MC", "Chen Q", "Liu H", "Peterson NB", "Dai Q", "Levy M", "Shah A", "Han X", "Ruan X", "Jiang M", "Li Y", "Julien JS", "Warner J", "Friedman C", "Roden DM", "Denny JC"], "date": "2015-01-01T00:00:00Z", "doi": "10.1136/amiajnl-2014-002649", "meta_date_publication": "2015 Jan", "meta_volume": "22", "meta_issue": "1", "meta_pages": "179-91", "score": 50051.617, "text_hl": "Many site-specific @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancers@@@ including @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@breast, colorectal, lung, and prostate@@@ demonstrated reduced mortality with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use in at least one EHR.", "citations": {"NLM": "Xu H, Aldrich MC, Chen Q, Liu H, Peterson NB, Dai Q, Levy M, Shah A, Han X, Ruan X, Jiang M, Li Y, Julien JS, Warner J, Friedman C, Roden DM, Denny JC. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality J Am Med Inform Assoc. 2015 Jan;22(1):179-91. PMID: 25053577", "BibTeX": "@article{25053577, title={Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality}, author={Xu H and Aldrich MC and Chen Q and Liu H and Peterson NB and Dai Q and Levy M and Shah A and Han X and Ruan X and Jiang M and Li Y and Julien JS and Warner J and Friedman C and Roden DM and Denny JC}, journal={J Am Med Inform Assoc}, volume={22}, number={1}, pages={179-91}}"}}, {"_id": "29635803", "pmid": 29635803, "title": "Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin.", "journal": "Prostate", "authors": ["Landim BC", "de Jesus MM", "Bosque BP", "Zanon RG", "da Silva CV", "Góes RM", "Ribeiro DL"], "date": "2018-07-01T00:00:00Z", "doi": "10.1002/pros.23517", "meta_date_publication": "2018 Jul", "meta_volume": "78", "meta_issue": "10", "meta_pages": "731-742", "score": 50051.168, "text_hl": "Stimulating effect of @CHEMICAL_Palmitates @CHEMICAL_MESH:D010168 @@@palmitate@@@ and @GENE_INS @GENE_3630 @@@insulin@@@ on cell migration and proliferation in @CELLLINE_CVCL:2163 @@@PNT1A@@@ and @CELLLINE_CVCL:0035 @@@PC3@@@ @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate@@@ cells: Counteracting role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Landim BC, de Jesus MM, Bosque BP, Zanon RG, da Silva CV, Góes RM, Ribeiro DL. Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin. Prostate. 2018 Jul;78(10):731-742. PMID: 29635803", "BibTeX": "@article{29635803, title={Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin.}, author={Landim BC and de Jesus MM and Bosque BP and Zanon RG and da Silva CV and Góes RM and Ribeiro DL}, journal={Prostate}, volume={78}, number={10}, pages={731-742}}"}}, {"_id": "29342230", "pmid": 29342230, "title": "Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.", "journal": "Acta Biochim Biophys Sin (Shanghai)", "authors": ["Saini N", "Yang X"], "date": "2018-02-01T00:00:00Z", "doi": "10.1093/abbs/gmx106", "meta_date_publication": "2018 Feb 1", "meta_volume": "50", "meta_issue": "2", "meta_pages": "133-143", "score": 50046.676, "text_hl": "Studies using various @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ models, including @DISEASE_Hereditary_Breast_and_Ovarian_Cancer_Syndrome @DISEASE_MESH:D061325 @@@breast@@@, @DISEASE_Pancreatitis @DISEASE_MESH:D010195 @@@pancreatic@@@, @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate@@@, and colon, have demonstrated the potency of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in attenuating CSCs through the targeting of specific pathways involved in cell differentiation, renewal, @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@metastasis@@@, and metabolism. ", "citations": {"NLM": "Saini N, Yang X. Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):133-143. PMID: 29342230", "BibTeX": "@article{29342230, title={Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.}, author={Saini N and Yang X}, journal={Acta Biochim Biophys Sin (Shanghai)}, volume={50}, number={2}, pages={133-143}}"}}]}